Neng Zhu Selected Research

Neng Zhu Research Topics

Disease

11	Neoplasms (Cancer) 01/2022 - 01/2008
6	Inflammation (Inflammations) 01/2022 - 07/2013
4	Atherosclerosis 01/2020 - 09/2014
3	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2008
3	Renal Cell Carcinoma (Grawitz Tumor) 09/2021 - 11/2020
2	Carcinogenesis 11/2021 - 01/2018
2	Hyperplasia 01/2021 - 01/2019
2	Obesity 12/2019 - 01/2018
2	Sepsis (Septicemia) 08/2014 - 07/2013
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Carcinoma (Carcinomatosis) 01/2020
1	Atherosclerotic Plaque (Atheroma) 01/2020
1	Cachexia 12/2019
1	Vascular Diseases (Vascular Disease) 01/2019
1	Neointima 01/2019
1	Pathologic Processes 01/2019
1	Hyperlipidemias (Hyperlipidemia) 01/2018
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 01/2018
1	Necrosis 07/2013
1	Hepatocellular Carcinoma (Hepatoma) 01/2008

Drug/Important Bio-Agent (IBA)

8	CholesterolIBA 01/2022 - 09/2014
6	LipidsIBA 01/2022 - 03/2016
2	CytokinesIBA 11/2021 - 01/2018
2	celastrolIBA 09/2021 - 01/2021
2	ATP-Binding Cassette Transporters (ABC Transporters)IBA 09/2021 - 01/2020
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2020 - 01/2008
2	salicylhydroxamic acid (SHAM)IBA 08/2014 - 07/2013
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022
1	EnzymesIBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	Sterol Regulatory Element Binding ProteinsIBA 01/2022
1	oxidized low density lipoproteinIBA 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	LDL Receptors (LDL Receptor)IBA 01/2022
1	Class E Scavenger Receptors (Lectin Like Oxidized Low Density Lipoprotein Receptor 1)IBA 01/2022
1	HDL LipoproteinsIBA 11/2021
1	Messenger RNA (mRNA)IBA 09/2021
1	Liver X ReceptorsIBA 09/2021
1	ATP Binding Cassette Transporter 1IBA 09/2021
1	TriterpenesIBA 01/2021
1	AdiponectinIBA 01/2021
1	steroid receptor RNA activatorIBA 11/2020
1	LipopolysaccharidesIBA 01/2020
1	SaponinsIBA 01/2020
1	7-ketocholesterolIBA 01/2020
1	CyclodextrinsIBA 01/2020
1	AldehydesIBA 01/2020
1	Adenosine Triphosphate (ATP)IBA 01/2020
1	Receptor Tyrosine Kinase-like Orphan ReceptorsIBA 01/2020
1	AdipokinesIBA 12/2019
1	Thyroid HormonesIBA 01/2019
1	LeptinIBA 01/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	Long Noncoding RNAIBA 01/2019
1	Insulin (Novolin)FDA Link 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Estrogens (Estrogen)FDA Link 08/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2016
1	p38 Mitogen-Activated Protein KinasesIBA 08/2016
1	Caveolin 1IBA 03/2016
1	Ezetimibe (Zetia)FDA Link 02/2016
1	sodium bisulfide (NaHS)IBA 08/2014
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 08/2014
1	Interleukin-10 (Interleukin 10)IBA 08/2014
1	ImmunosorbentsIBA 07/2013
1	urinastatin (MR 20)IBA 07/2013
1	InterleukinsIBA 07/2013

Therapy/Procedure

4	Therapeutics 01/2022 - 12/2019
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2021
1	Drug Therapy (Chemotherapy) 12/2019